Agenus to Present agenT-797 Long-Term Data at SITC 2026
AGenus said it will present BOT+BAL long-term survival data and translational research with agenT-797 in colorectal cancer at SITC 2026.
AGenus said it will present BOT+BAL long-term survival data and translational research with agenT-797 in colorectal cancer at SITC 2026.